Lockheed Martin (LMT) Stock Slides as Market Rises: Facts to Know Before You Trade

Lockheed Martin (LMT) stock declined 1.03% in the latest session, underperforming a gaining market, despite a robust 8.99% rise over the past month. The company is set to report an anticipated quarterly EPS of $6.33, a 7.46% year-over-year decrease, even as revenue is expected to climb 8.41% to $18.54 billion; full-year EPS is projected to fall 23.22% while revenue increases 4.49%. LMT currently trades at a forward P/E of 21.22, a discount to its industry average of 25.93, and holds a Zacks Rank #3 (Hold), with recent analyst EPS estimates showing a slight positive revision.

Analysis

Lockheed Martin (LMT) presents a mixed financial picture, characterized by recent stock momentum clashing with concerning forward-looking earnings estimates. Despite a minor daily pullback of 1.03%, the stock has significantly outperformed its sector and the broader market over the past month with an 8.99% gain. However, upcoming earnings are projected to show a notable divergence: consensus estimates point to an 8.41% year-over-year revenue increase to $18.54 billion, but a 7.46% decline in quarterly EPS to $6.33. This trend of margin pressure appears to extend throughout the fiscal year, with full-year revenue expected to rise 4.49% while EPS is projected to fall sharply by 23.22%. On a positive note, consensus EPS estimates have seen a slight upward revision of 0.24% in the last 30 days, and the stock trades at a discounted Forward P/E of 21.22 compared to its industry's average of 25.93. This is tempered by a PEG ratio of 2.07, slightly above the industry average, suggesting the price may be fair relative to its expected growth. The stock's neutral Zacks Rank #3 (Hold) rating reflects this combination of strong industry positioning, solid revenue growth, and significant profitability headwinds.

Key Decisions for Investors

• Investors should closely scrutinize the upcoming earnings report for management's explanation of the margin compression driving the projected 7.46% quarterly EPS decline despite an 8.41% revenue increase.
• Given the stock's recent 8.99% monthly gain, consider whether the positive revenue outlook is already priced in, as the full-year EPS forecast shows a significant 23.22% decline.
• The stock's discounted forward P/E offers a potential value argument, but the neutral 'Hold' rating and negative earnings trajectory warrant a cautious stance pending clarification on the path to restoring profitability.